169 related articles for article (PubMed ID: 29091040)
1. A Pilot Study to Evaluate the Effects of Perfusion-decellularized Porcine Hepatic-derived Wound Matrix on Difficult-to-heal Diabetic Foot Ulcers.
Fridman R; Engelhardt J
Wounds; 2017 Oct; 29(10):317-323. PubMed ID: 29091040
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Hard-to-heal Diabetic Foot Ulcers With a Hepatic-derived Wound Matrix.
Fridman R; Rafat P; Van Gils CC; Horn D; Vayser D; Lambert JC
Wounds; 2020 Sep; 32(9):244-252. PubMed ID: 32813669
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of tissue engineering products for the management of neuropathic diabetic foot ulcers: an interim analysis.
Frykberg RG; Cazzell SM; Arroyo-Rivera J; Tallis A; Reyzelman AM; Saba F; Warren L; Stouch BC; Gilbert TW
J Wound Care; 2016 Jul; 25(Sup7):S18-S25. PubMed ID: 29027848
[TBL] [Abstract][Full Text] [Related]
4. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers.
Mutluoglu M; Uzun G; Bennett M; Germonpré P; Smart D; Mathieu D
Diving Hyperb Med; 2016 Sep; 46(3):133-134. PubMed ID: 27723012
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of a porcine peritoneum-derived matrix in diabetic foot ulcer treatment: a pilot study.
Ai-Jalodi O; Sabo M; Patel K; Bullock N; Serena L; Breisinger K; Serena TE
J Wound Care; 2021 Feb; 30(Sup2):S18-S23. PubMed ID: 33573495
[TBL] [Abstract][Full Text] [Related]
6. Treatment of diabetic foot ulcers with dehydrated amniotic membrane allograft: a prospective case series.
Abdo RJ
J Wound Care; 2016 Jul; 25(Sup7):S4-S9. PubMed ID: 29027851
[TBL] [Abstract][Full Text] [Related]
7. An observational pilot study using a purified reconstituted bilayer matrix to treat non-healing diabetic foot ulcers.
Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; Zelen CM
Int Wound J; 2020 Aug; 17(4):966-973. PubMed ID: 32266774
[TBL] [Abstract][Full Text] [Related]
8. A pilot study evaluating non-contact low-frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers.
Yao M; Hasturk H; Kantarci A; Gu G; Garcia-Lavin S; Fabbi M; Park N; Hayashi H; Attala K; French MA; Driver VR
Int Wound J; 2014 Dec; 11(6):586-93. PubMed ID: 23163982
[TBL] [Abstract][Full Text] [Related]
9. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
Driver VR; Reyzelman A; Kawalec J; French M
Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
[TBL] [Abstract][Full Text] [Related]
10. A prospective, randomised, controlled, multicentre clinical trial examining healing rates, safety and cost to closure of an acellular reticular allogenic human dermis versus standard of care in the treatment of chronic diabetic foot ulcers.
Zelen CM; Orgill DP; Serena T; Galiano R; Carter MJ; DiDomenico LA; Keller J; Kaufman J; Li WW
Int Wound J; 2017 Apr; 14(2):307-315. PubMed ID: 27073000
[TBL] [Abstract][Full Text] [Related]
11. A Prospective, Descriptive Study to Assess the Clinical Benefits of Using Calendula officinalis Hydroglycolic Extract for the Topical Treatment of Diabetic Foot Ulcers.
Buzzi M; de Freitas F; Winter M
Ostomy Wound Manage; 2016 Mar; 62(3):8-24. PubMed ID: 26978856
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of fluorescence biomodulation in the real-life management of chronic wounds: the EUREKA trial.
Romanelli M; Piaggesi A; Scapagnini G; Dini V; Janowska A; Iacopi E; Scarpa C; Fauverghe S; Bassetto F;
J Wound Care; 2018 Nov; 27(11):744-753. PubMed ID: 30398941
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of a polyhydrated ionogen impregnated dressing in the treatment of recalcitrant diabetic foot ulcers: a multi-centre pilot study.
Pirayesh A; Dessy LA; Rogge FJ; Hoeksema HJ; Sinove YM; Dall' Antonia A; Jawad MA; Gilbert PM; Rubino C; Scuderi N; Blondeel R; Monstrey S
Acta Chir Belg; 2007; 107(6):675-81. PubMed ID: 18274183
[TBL] [Abstract][Full Text] [Related]
14. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
[TBL] [Abstract][Full Text] [Related]
15. A Retrospective Case Series of a Dehydrated Amniotic Membrane Allograft for Treatment of Unresolved Diabetic Foot Ulcers.
Rosenblum BI
J Am Podiatr Med Assoc; 2016 Sep; 106(5):328-337. PubMed ID: 27439322
[TBL] [Abstract][Full Text] [Related]
16. Human placental membrane as a wound cover for chronic diabetic foot ulcers: a prospective, postmarket, CLOSURE study.
Pacaccio DJ; Cazzell SM; Halperin GJ; Kasper MA; Neutel JM; O'Carroll BD; Reyzelman AM
J Wound Care; 2018 Jul; 27(Sup7):S28-S37. PubMed ID: 30008251
[TBL] [Abstract][Full Text] [Related]
17. Human acellular dermal wound matrix for treatment of DFU: literature review and analysis.
Reyzelman AM; Bazarov I
J Wound Care; 2015 Mar; 24(3):128; 129-34. PubMed ID: 25764957
[TBL] [Abstract][Full Text] [Related]
18. A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing by 12 weeks.
Snyder RJ; Cardinal M; Dauphinée DM; Stavosky J
Ostomy Wound Manage; 2010 Mar; 56(3):44-50. PubMed ID: 20368673
[TBL] [Abstract][Full Text] [Related]
19. Clinical Achievement of Wound Closure and Tissue Quality With a Novel Microvascular Tissue Graft.
Zelen CM; Gould LJ; Li WW
Wounds; 2019 Apr; 31(4):E29-E32. PubMed ID: 31008717
[TBL] [Abstract][Full Text] [Related]
20. The efficacy and safety of Grafix(®) for the treatment of chronic diabetic foot ulcers: results of a multi-centre, controlled, randomised, blinded, clinical trial.
Lavery LA; Fulmer J; Shebetka KA; Regulski M; Vayser D; Fried D; Kashefsky H; Owings TM; Nadarajah J;
Int Wound J; 2014 Oct; 11(5):554-60. PubMed ID: 25048468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
